Prognostic assays for rejection and tolerance in organ transplantation.
In this review, I have summarised our understanding of acute rejection of organ transplants, and for convenience I have identified three processes, recognition, rejection and regulation. In stark contrast to this text-book picture of acute rejection, I have drawn attention to some of the clinical realities, where processes are altered by powerful immunosuppressive drugs, and where many transplant recipients are pre-sensitised to transplantation antigens prior to engraftment. The ultimate goal is to encourage the emergence of a utopian immunological state, wherein patients tolerate organ transplants for life after being weaned from all immunosuppressive drugs. Assays that may be used in the future to reliably monitor this process are still at a very exciting stage of development.
Bradley
Benjamin A
BA
The East Barn, The Pound, Lower Almondsbury, Bristol BS32 4EF, England, United Kingdom. Benjamin.Bradley@btinternet.com
D000818:Animals; D006084:Graft Rejection / Q000188:drug therapy / Q000276:immunology*; D006801:Humans; D007158:Immunologic Techniques; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D016377:Organ Transplantation; D011379:Prognosis; D014181:Transplantation Immunology; D023001:Transplantation Tolerance / Q000187:drug effects / Q000276:immunology*
D007166:Immunosuppressive Agents